IP Library Granted Patent US 8,613,766
Granted Patent B2
US 8,613,766 · App. 11/961,420 · Granted Dec 24, 2013

Multi-element accommodative intraocular lens

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,613,766
App. No.
11/961,420
Granted
Dec 24, 2013
Kind
B2
Abstract

A multi-element accommodating intraocular lens (AIOL) having a first anterior translation member and a first posterior translation member coupled together to form a first bias element. The first posterior translation member has a greater resistance to bending than the first anterior translation member. The first posterior translation member has a greater thickness than the first anterior translation member.

Claims (75)

1. A multi-element accommodating intraocular lens (AIOL) having an optical axis, comprising:

(A.) an anterior portion comprising—

(i.) an anterior optical element, and

(ii.) a first anterior translation member coupled to the anterior optical element, and

(iii.) a second anterior translation member coupled to the anterior optical element, and

(B.) a posterior portion comprising—

(i.) a posterior optical element

(ii.) a first posterior translation member coupled to the posterior optical element, and

(iii.) a second posterior translation member coupled to the posterior optical element, and

the first anterior translation member and first posterior translation member being integrally connected to form a first single piece bias element, and the second anterior translation member and the second posterior translation member integrally connected to form a second single piece bias element,

wherein the first posterior translation member has a greater resistance to bending than the first anterior translation member, and the second posterior translation member has a greater resistance to bending than the second anterior translation member,

the first posterior translation member having a resistance to bending such that, at a point disposed at least 75% of the distance from the optical axis to the radially outermost location of the first bias element, a force of 0.1 mN causes less than 0.2 mm of displacement, when the lens is in an unstressed state.

2. The AIOL of claim 1 , wherein the force of 0.1 mN causes less than 0.1 mm of displacement.

3. The AIOL of claim 1 , wherein the force of 0.1 mN causes less than 0.065 mm of displacement.

4. The AIOL of claim 1 , further comprising a third biasing element coupled to the anterior optical element and the posterior element.

5. The AIOL of claim 4 , further comprising a fourth biasing element coupled to the anterior optical element and the posterior element.

6. The AIOL of claim 1 , wherein the first posterior translation member has a greater thickness than the first anterior translation member.

7. The AIOL of claim 1 , wherein the first posterior translation member has a greater thickness than the first anterior translation member over at least 50% of the first posterior translation member length.

8. The AIOL of claim 1 , wherein the anterior optical element is recessed relative to the first bias element and the second bias element.

9. The AIOL of claim 1 , wherein the first anterior translation member and first posterior translation member are coupled together to form an angulated connection.

10. The AIOL of claim 1 , wherein the first anterior translation member and first posterior translation member coupled together to form a curved connection.

11. The AIOL of claim 1 , wherein the first anterior translation member is coupled to the anterior optical element at an anterior attachment location, and wherein the point is located at least 50% of the radial distance from the anterior attachment location to the radially outermost location.

12. The AIOL of claim 1 , wherein the anterior optical element has a positive optical power and the posterior optical element has a negative optical power.

13. A multi-element accommodating intraocular lens (AIOL), comprising:

(A.) an anterior portion comprising—

(i.) an anterior optical element, and

(ii.) a first anterior translation member coupled to the anterior optical element at a first attachment location, and

(iii.) a second anterior translation member coupled to the anterior optical element at a second attachment location, and

(B.) a posterior portion comprising—

(i.) a posterior optical element

(ii.) a first posterior translation member coupled to the posterior optical element at a third attachment location, and

(iii.) a second posterior translation member coupled to the posterior optical element at a fourth attachment locations, and

the first anterior translation member and first posterior translation member integrally connected to form a first single piece bias element, and the second anterior translation member and the second posterior translation member integrally connected to form a second single piece bias element,

the first posterior translation member having a greater resistance to bending about the third attachment location than the first anterior translation member has about the first attachment location.

14. The AIOL of claim 13 , further comprising a third biasing element coupled to the anterior optical element and the posterior element.

15. The AIOL of claim 14 , further comprising a fourth biasing element coupled to the anterior optical element and the posterior element.

16. The AIOL of claim 13 , wherein the first posterior translation member has a greater thickness than the first anterior translation member.

17. The AIOL of claim 13 , wherein the first posterior translation member has a greater thickness than the first anterior translation member over at least 50% of the first posterior translation member length.

18. The AIOL of claim 13 , wherein the anterior optical element is recessed relative to the first bias element and the second bias element.

19. The AIOL of claim 13 , wherein the first anterior translation member and first posterior translation member are coupled together to form an angulated connection.

20. The AIOL of claim 13 , wherein the first anterior translation member and first posterior translation member coupled together to form a curved connection.

21. The AIOL of claim 13 , wherein the point is located at least 50% of the radial distance from the first attachment location to the radially outermost location of the first bias element.

22. The AIOL of claim 13 , wherein the anterior optical element has a positive optical power and the posterior optical element has a negative optical power.

23. A multi-element accommodating intraocular lens (AIOL), comprising:

(A.) an anterior portion comprising—

(i.) an anterior optical element, and

(ii.) a first anterior translation member coupled to the anterior optical element, and

(iii.) a second anterior translation member coupled to the anterior optical element, and

(B.) a posterior portion comprising—

(i.) a posterior optical element

(ii.) a first posterior translation member coupled to the posterior optical element, and

(iii.) a second posterior translation member coupled to the posterior optical element, and

the first anterior translation member and first posterior translation member integrally connected to form a first single piece bias element, and the second anterior translation member and the second posterior translation member integrally connected to form a second single piece bias element,

the first posterior translation member having a greater thickness than the first anterior translation member.

24. The AIOL of claim 23 , further comprising a third biasing element coupled to the anterior optical element and the posterior element.

25. The AIOL of claim 24 , further comprising a fourth biasing element coupled to the anterior optical element and the posterior element.

26. The AIOL of claim 23 , wherein the first posterior translation member has a greater thickness than the first anterior translation member over at least 50% of the first posterior translation member length.

27. The AIOL of claim 23 , wherein the anterior optical element is recessed relative to the first bias element and the second bias element.

28. The AIOL of claim 23 , wherein the first anterior translation member and first posterior translation member are coupled together to form an angulated connection.

29. The AIOL of claim 23 , wherein the first anterior translation member and first posterior translation member coupled together to form a curved connection.

30. The AIOL of claim 23 , wherein the anterior optical element has a positive optical power and the posterior optical element has a negative optical power.

31. A multi-element accommodating intraocular lens (AIOL) having an optical axis, comprising:

(A.) an anterior portion comprising—

(i.) an anterior optical element, and

(ii.) a first anterior translation member coupled to the anterior optical element at a first attachment location, and

(iii.) a second anterior translation member coupled to the anterior optical element at a second attachment location, and

(B.) a posterior portion comprising—

(i.) a posterior optical element

(ii.) a first posterior translation member coupled to the posterior optical element at a third attachment location, and

(iii.) a second posterior translation member coupled to the posterior optical element at a fourth attachment location, and

the first anterior translation member and first posterior translation member coupled together to form a first bias element, and the second anterior translation member and the second posterior translation member coupled together to form a second bias element, and

wherein the first posterior translation member has a greater resistance to bending than the first anterior translation member, and the second posterior translation member has a greater resistance to bending than the second anterior translation member,

a plane perpendicular to the optical axis and passing through the radially outermost location of each bias element is closer to the first attachment location than the third attachment location.

32. The AIOL of claim 31 , wherein the plane is closer to first attachment location than the third attachment location, when the AIOL is in an accommodative state.

33. The AIOL of claim 31 , wherein the plane is closer to first attachment location than the third attachment location, when the AIOL is in an disaccommodative state.

Assignments (27)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
Reel/Frame 073654/0242 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 073637/0001 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
Reel/Frame 073637/0126 →
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (059913/0548) Recorded Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072469/0091 →
PATENT SECURITY AGREEMENT Recorded Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
PATENT SECURITY AGREEMENT Recorded Oct 4, 2023
From: BAUSCH & LOMB INCORPORATED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 065120/0086 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 059121/0001) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061873/0001 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 043251/0932) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 061872/0099 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 045444/0634) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; LABORATOIRE CHAUVIN S.A.S.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0295 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 048556/0758) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH COMPANIES INC.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0484 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 056811/0814) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061872/0669 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 045444/0299) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; PF CONSUMER HEALTHCARE 1 LLC; LABORATOIRE CHAUVIN S.A.S.
Reel/Frame 061779/0001 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 031156/0508) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061778/0446 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 034749/0689) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; UNIVERSITY OF ROCHESTER
Reel/Frame 061778/0146 →
PATENT SECURITY AGREEMENT Recorded May 10, 2022
From: BAUSCH & LOMB INCORPORATED
To: CITIBANK, N.A. AS COLLATERAL AGENT
Reel/Frame 059913/0548 →
SECURITY AGREEMENT Recorded Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
SECURITY INTEREST Recorded Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
SECURITY INTEREST Recorded Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
SECURITY INTEREST Recorded Jul 19, 2017
From: BAUSCH & LOMB INCORPORATED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043251/0932 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
SECURITY AGREEMENT Recorded Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2008
From: RICHARDSON, GARY A.; ENIN, JOSH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 020415/0684 →